Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Completed · Phase 3 · Has a placebo group
Conditions studied: Kidney Cancer
In brief
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether monoclonal antibody therapy is effective in treating kidney cancer. PURPOSE: This randomized phase III trial is studying monoclonal antibody therapy to see how well it works in treating patients who have undergone surgery for nonmetastatic primary kidney cancer.
Key facts
- Study ID
- NCT00087022
- Run by
- Heidelberg Pharma AG
- People needed
- 864
- Starts
- 2004-07-01
- Expected to finish
- 2012-10-01
- Last updated by the study team
- 2018-11-27
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Helen F. Graham Cancer Center at Christiana Hospital — Newark, Delaware, United States
- Atlantic Urological Associates - Daytona Beach — Daytona Beach, Florida, United States
- Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
- Southeastern Research Group — Tallahassee, Florida, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- Augusta Oncology Associates - Walton Way — Augusta, Georgia, United States
- North Idaho Urology - Coeur d'Alene — Coeur d'Alene, Idaho, United States
- Northeast Indiana Urology, PC — Fort Wayne, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
- Hematology and Oncology Specialists, LLC - Metairie — Metairie, Louisiana, United States
- Regional Urology, LLC — Shreveport, Louisiana, United States
- Feist-Weiller Cancer Center at Louisiana State University Health Sciences — Shreveport, Louisiana, United States
- Werner-Francis Urology Associates, LLC — Greenbelt, Maryland, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Lahey Clinic Medical Center - Burlington — Burlington, Massachusetts, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis — St Louis, Missouri, United States
- Nevada Cancer Institute — Las Vegas, Nevada, United States
- Community Care Physicians, PC at Urological Institute of NENY — Albany, New York, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- AccuMed Research Associates — Garden City, New York, United States
- Mount Sinai School of Medicine — New York, New York, United States
- Hudson Valley Urology, PC — Poughkeepsie, New York, United States
- Study site — Anchorage, Alaska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.